Cubist Systematic Strategies, LLC Novartis Ag Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $8.3 Million - $9.45 Million	87,081 Added 157.8%	142,265 $13.8 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $2.2 Million - $2.42 Million	23,827 Added 75.99%	55,184 $5.57 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $5.79 Million - $6.42 Million	-61,100 Reduced 66.08%	31,357 $3.19 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $8.42 Million - $9.55 Million	91,057 Added 6504.07%	92,457 $9.33 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $497,146 - $576,535	-6,212 Reduced 81.61%	1,400 $128,000
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $3.5 Million - $4.28 Million	-46,284 Reduced 85.88%	7,612 $690,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $711,630 - $832,285	-9,538 Reduced 15.04%	53,896 $4.1 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $711,630 - $832,285	-9,538 Reduced 15.04%	53,896 $4.1 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $2.1 Million - $2.45 Million	26,138 Added 70.08%	63,434 $5.36 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $8.21 Million - $9.29 Million	-102,529 Reduced 73.33%	37,296 $3.27 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $10.4 Million - $11.5 Million	129,992 Added 1322.0%	139,825 $12.2 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $1.9 Million - $2.21 Million	-23,207 Reduced 70.24%	9,833 $804,000
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $913,858 - $1.01 Million	10,721 Added 48.04%	33,040 $3.02 Million
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $1.69 Million - $1.99 Million	20,182 Added 944.41%	22,319 $1.91 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $146,849 - $177,622	-1,881 Reduced 46.81%	2,137 $202,000
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $25,791 - $28,574	314 Added 8.48%	4,018 $349,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $1.01 Million - $1.13 Million	-12,456 Reduced 77.08%	3,704 $324,000
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $650,800 - $911,783	-9,209 Reduced 36.3%	16,160 $1.33 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $1.73 Million - $1.95 Million	20,465 Added 417.31%	25,369 $2.4 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $221,120 - $243,662	-2,585 Reduced 34.52%	4,904 $426,000
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $51,649 - $63,568	685 Added 10.07%	7,489 $684,000
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $438,588 - $501,651	-5,823 Reduced 46.12%	6,804 $654,000
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $227,167 - $252,949	-3,084 Reduced 19.63%	12,627 $1.08 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $329,813 - $381,497	-4,927 Reduced 23.87%	15,711 $1.35 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $931,069 - $1.05 Million	14,344 Added 227.9%	20,638 $1.56 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $13,092 - $15,651	-186 Reduced 2.87%	6,294 $509,000
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $225,090 - $241,615	3,112 Added 92.4%	6,480 $544,000
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $249,703 - $260,245	3,368	3,368 $289,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account